Pharma channel feed

Mer­ck chop­ping 140-plus staffers out of Ac­celeron in wake of $11.5B buy­out

4 years ago
People

Ex­clu­sive: Fol­low­ing a se­vere set­back, Bridge­Bio brings out the bud­get axe to chop staff but keeps qui­et on the num­bers

4 years ago

Safe­ty con­cerns lead FDA to re­ject Ake­bi­a's kid­ney drug

4 years ago
FDA+

Pre­ci­sion di­ag­nos­tics biotech wins newest round of in­vestor back­ing in bid to fa­cil­i­tate com­pa­ny ex­pan­sion

4 years ago
Diagnostics

As shares tank, Or­chard once again re­struc­tures, shed­ding gene ther­a­py pro­grams and a large part of the staff

4 years ago
People

A team at Penn says it has slashed CAR-T cell ther­a­py man­u­fac­tur­ing time­frame to just 24 hours

4 years ago
Cell/Gene Tx
Manufacturing

Fed­er­al ap­peals court bats back claims No­vo Nordisk’s di­a­betes drug trig­gers pan­cre­at­ic can­cer

4 years ago
Law

EMA to clin­i­cal tri­al spon­sors: Use your Covid-re­lat­ed flex­i­bil­i­ties in re­spond­ing to Ukraine cri­sis

4 years ago

Fed watch­dog con­firms Trump-era Covid ad cam­paign shenani­gans — and mil­lions mis­spent

4 years ago
FDA+
Marketing

No­var­tis preps launch of Leqvio cam­paign af­ter Acad­e­my Awards ‘splash’

4 years ago
Marketing

Pe­ter Hotez and Maria Bot­tazz­i's 'for­got­ten' vac­cine ap­proved in Botswana

4 years ago
Coronavirus
Manufacturing

Af­ter fail­ing bad­ly on the new com­mer­cial­iza­tion front, Zealand slash­es US staff, sends off CEO and piv­ots back to R&D

4 years ago
People

In a bid to push be­yond fi­nan­cial hub sta­tus, Ca­nary Wharf plots £500M wet lab build­ing

4 years ago

De­spite 'los­ing mon­ey' in Rus­sia, Roche com­mits to con­tin­u­ing its sup­ply of es­sen­tial med­i­cines — re­port

4 years ago

With­out an ad­comm, FDA signs off on sec­ond Covid-19 boost­er for those over 50

4 years ago
Coronavirus

Af­ter rais­ing claims Bridge­Bio wild­ly over­paid di­rec­tors, the ac­cuser wants a $4M re­ward

4 years ago
Law

Pur­due shells out a lit­tle more cash for a non-prof­it biotech work­ing on nalox­one OTC nasal spray

4 years ago
Law

Bel­gian CD­MO of­fers new LNP ser­vice as de­mand for RNA-de­liv­ery ser­vices heats up

4 years ago
Manufacturing

Mar­ket­ingRx roundup: No­vo Nordisk Type 1 cy­cling team stars in doc­u­men­tary; GSK, Vi­a­tris, Vi­iV top in­no­va­tion list

4 years ago
Marketing

GSK and Med­ica­go have glob­al plans for their Covid-19 vac­cine. But WHO balks at Big To­bac­co in­vestor

4 years ago

Eli Lil­ly ver­sus the 800-pound go­ril­la in atopic der­mati­tis? It may just have a shot — at 2nd place

4 years ago
R&D

Roche’s Genen­tech re­news MS cam­paign aimed at ‘break­ing bar­ri­ers’ for un­der­rep­re­sent­ed pa­tients

4 years ago
Marketing

Jazz plots mas­sive growth for UK cannabi­noid op­er­a­tions

4 years ago
Manufacturing

In quick turn, ten23 al­ready look­ing to ex­pand Visp fill-fin­ish site

4 years ago
Manufacturing
First page Previous page 212213214215216217218 Next page Last page
A service from the Financial Times